Advertisement
UK markets closed
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • CRUDE OIL

    83.08
    +1.73 (+2.13%)
     
  • GOLD FUTURES

    2,241.70
    +29.00 (+1.31%)
     
  • DOW

    39,835.17
    +75.09 (+0.19%)
     
  • Bitcoin GBP

    56,062.87
    +1,534.33 (+2.81%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,401.70
    +2.18 (+0.01%)
     
  • UK FTSE All Share

    4,338.05
    +12.12 (+0.28%)
     

Cell and Gene Therapy Business Outlook 2023: Curated Analyses, Market Forecasting and Player Activity Updates

Company Logo
Company Logo

Dublin, Jan. 03, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Business Outlook" report has been added to ResearchAndMarkets.com's offering.

The Twice-Monthly Publication Cell and Gene Therapy Business Outlook will offer the following:

  • Market Sizing and Forecasting of CAGT Markets: Each issue sizes up the market opportunity and projects the future revenues for a given therapeutic segment.

  • Keeping an Eye on Financing: With billions of investment dollars announced each year, Cell and Gene Therapy Business Outlook tracks who is getting financed (and the companies behind the financing) each issue. On a regular basis we will analyze trends in that financing.

  • News Briefs and Analysis of the Science That will Shape Tomorrow's Business: Cell and Gene Therapy Business Outlook is designed to provide the most relevant news. With a focus on what the recent news of the day means for business, our curated news and news analysis means that you and your organization can be confident you won't miss an important development in cell and gene therapy.

  • Deals Between CAGT Companies Tracked: Each issue's "Recent Deals Table" tracks the important deals between stem cell companies as well as the deals they engage in (tech transfers, partnerships, mergers, distribution and other activities) with companies outside the industry.

  • Cell and Gene Therapy Tools: This newsletter will also report on developments, product launches and deals relating to the makers of cell and gene therapy manufacturing equipment and supplies.

Target Audience Includes:

  • Director, Vice President or Manager of Market Research

  • Director, Vice President or Manager of Marketing

  • Director, Vice President or Manager of Research and Development

  • Director of Business Insights

  • Director of Business Development

  • CEO

ADVERTISEMENT

For more information about this report visit https://www.researchandmarkets.com/r/mhlg5b

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900